Skip to main content
Log in

High-risk HPV infection modulates the promoter hypermethylation of APC, SFRP1, and PTEN in cervical cancer patients of North India

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Persistent infection with oncogenic HPV and downregulation of tumor suppressor genes play an essential role in the development and progression of cervical cancer. The present study aimed to identify the promoter methylation status of APC, SFRP1, and PTEN which are important regulators of Wnt pathway and their association with high-risk HPV infection and gene expression. Methylation Specific PCR (MSP) and quantitative reverse transcription PCR (RT-qPCR) were used to detect methylation status and gene expression levels of APC, SFRP1, and PTEN in cervical cancer biopsies (110) and paired non-cancerous biopsies (28). APC promoter was methylated in 38%, SFRP1 in 95%, and PTEN in 55% of the cervical cancer biopsies. Our data showed a trend of a higher rate of methylation of the gene promoters in cervical cancer biopsies while; they were majorly un-methylated in non-cancerous biopsies. Corresponding to a higher rate of methylation in cancer biopsies, the gene expression levels of APC, SFRP1, and PTEN were reduced in cervical cancer samples in comparison to normal cervix tissues. Further, we observed that 97% cancer biopsies were HPV infected and high-risk type HPV16 and 18 infections were significantly positively associated with APC (p = 0.008 and p = 0.007), SFRP1 (p = 0.003 and p = 0.0067), and PTEN (p = 0.049 and p = 0.008) promoter methylation. APC, SFRP1, and PTEN promoter hyper-methylation is positively associated with high-risk HPV infection and inversely associated with gene expression. Our findings show that high-risk HPV infection promotes methylation of these genes and further promotes their silencing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

IHEC:

Institutional human ethical committee

qRT-PCR:

Quantitative real-time polymerase chain reaction

MSP:

Methylation specific PCR

HPV:

Human papillomavirus

References

  1. Moten A, Schafer D, Ferrari M (2014) Redefining global health priorities: improving cancer care in developing settings. J Glob Health 4.

  2. Sreedevi A, Javed R, Dinesh A (2015) Epidemiology of cervical cancer with special focus on India. Int J Womens Health 7:405–414

    PubMed  PubMed Central  Google Scholar 

  3. Weijzen S, Zlobin A, Braid M et al (2003) HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation. J Cell Physiol 194:356–362

    CAS  PubMed  Google Scholar 

  4. Pfeifer GP (2018) Defining driver DNA methylation changes in human cancer. Int J Mol Sci 19:1166

    PubMed Central  Google Scholar 

  5. Tai D, Wells K, Arcaroli J, Vanderbilt C, Aisner DL, Messersmith WA, Lieu CH (2015) Targeting the WNT signaling pathway in cancer therapeutics. Oncologist 20:1189

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Arnold CN, Goel A, Niedzwiecki D, Dowell JM, Wasserman L, Compton C, Mayer RJ, Bertagnolli MM, Boland CR (2004) APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q1. Cancer Biol Ther 3:960–964

    CAS  PubMed  Google Scholar 

  7. Koinuma K, Yamashita Y, Liu W, Hatanaka H, Kurashina K, Wada T, Takada S, Kaneda R, Choi YL, Fujiwara S-I, Miyakura Y, Nagai H, Mano H (2006) Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability. Oncogene 25:139–146

    CAS  PubMed  Google Scholar 

  8. Yu J, Tao Q, Cheng Y, Lee K, Ng S, Cheung K, Tian L, Rha S, Neumann U, Röcken C, Ebert M, Chan F, Sung J (2009) Promoter methylation of the WNT/β-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer. Cancer 115:49–60

    CAS  PubMed  Google Scholar 

  9. Qi J, Zhu Y-Q, Luo J, Tao W-H (2006) Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. World J Gastroenterol 12:7113

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Liang TJ, Wang HX, Zheng YY, Cao YQ, Wu X, Zhou X, Dong SX (2017) APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review. Oncotarget 8:46468

    PubMed  PubMed Central  Google Scholar 

  11. Brabender J, Usadel H, Danenberg KD, Metzger R, Schneider PM, Lord RV, Wickramasinghe K, Lum CE, Park J, Salonga D, Singer J (2001) Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene 20:3528–3532

    CAS  PubMed  Google Scholar 

  12. Matsuda Y, Schlange T, Oakeley EJ, Boulay A, Hynes NE (2009) WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth. Breast Cancer Res 11(3):R32

    PubMed  PubMed Central  Google Scholar 

  13. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW (1998) Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res 58:1130–1134

    CAS  PubMed  Google Scholar 

  14. Klarmann GJ, Decker A, Farrar W (2008) Epigenetic gene silencing in the WNT pathway in breast cancer. Epigenetics 3:59–63

    PubMed  PubMed Central  Google Scholar 

  15. Nojima M, Suzuki H, Toyota M, Watanabe Y, Maruyama R, Sasaki S, Sasaki Y, Mita H, Nishikawa N, Yamaguchi K, Hirata K (2007) Frequent epigenetic inactivation of SFRP genes and constitutive activation of WNT signaling in gastric cancer. Oncogene 26:4699–4713

    CAS  PubMed  Google Scholar 

  16. Salvesen HB, MacDonald N, Ryan A et al (2001) PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int J Cancer 91:22–26

    CAS  PubMed  Google Scholar 

  17. Kang Y-H, Lee HS, Kim WH (2002) Promoter methylation and silencing of PTEN in gastric carcinoma. Lab Invest 82:285–291

    CAS  PubMed  Google Scholar 

  18. Soria JC, Lee HY, Lee JI, Wang L, Issa JP, Kemp BL, Liu DD, Kurie JM, Mao L, Khuri F (2002) Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin Cancer Res 8:1178–1184

    CAS  PubMed  Google Scholar 

  19. Cates W Jr (1999) Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 26:S2-7

    PubMed  Google Scholar 

  20. Bosch FX, de Sanjosé S (2007) The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 23:213–227

    PubMed  PubMed Central  Google Scholar 

  21. Al-Shabanah OA, Hafez MM, Hassan ZK, Sayed-Ahmed MM, Abozeed WN, Alsheikh A, Al-Rejaie SS (2014) Methylation of SFRPs and APC genes in ovarian cancer infected with high risk human papillomavirus. Asian Pac J Cancer Prev 15:2719–2725

    PubMed  Google Scholar 

  22. Gubanova E, Brown B, Ivanov SV, Helleday T, Mills GB, Yarbrough WG, Issaeva N (2012) Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival. Clinical Cancer Res 18(5):1257–67

    CAS  Google Scholar 

  23. Marsit CJ, McCleanMD FCS, Kelsey K (2006) Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma. Int J Cancer 119:1761–1766

    CAS  PubMed  Google Scholar 

  24. Sartor MA, Dolinoy DC, Jones TR, Colacino JA, Prince ME, Carey TE, Rozek LS (2011) Genome-wide methylation and expression differences in HPV (+) and HPV (-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis. Epigenetics 6(6):777–787

    CAS  PubMed  PubMed Central  Google Scholar 

  25. van Kempen PM, Noorlag R, Braunius WW, Stegeman I, Willems SM, Grolman W (2014) Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a systematic review. Epigenetics 9(2):194–203

    PubMed  Google Scholar 

  26. Paschos K, Allday MJ (2010) Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends Microbiol 18:439–447

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Kadian LK, Singhal G, Sharma S, Chauhan P, Nanda S, Yadav R (2019) Incidence and ASSOCIATION of HPV16 and 18 with various risk factors in cervical cancer patients in population of Haryana Region, India. J Clin Diagnostic Res 13:10–13

    CAS  Google Scholar 

  28. Wisman GB, Nijhuis ER, Hoque MO, Reesink-Peters N, Koning AJ, Volders HH, Buikema HJ, Boezen HM, Hollema H, Schuuring E, Sidransky D (2006) Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer 119:1908–1914

    CAS  PubMed  Google Scholar 

  29. Truong P, Lao T, Le T (2007) Aberrant DNA methylation of adenomatous polyposis coli gene with high-risk human papillomavirus in Vietnamese patients. In: International conference on the development of biomedical engineering in Vietnam. Springer, pp 263–267

  30. Henrique R, Ribeiro FR, Fonseca D, Hoque MO, Carvalho AL, Costa VL, Pinto M, Oliveira J, Teixeira MR, Sidransky D, Jerónimo C (2007) High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients. Clinical Cancer Res 13:6122–6129

    CAS  Google Scholar 

  31. Lee BB, Lee EJ, Jung EH et al (2009) Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. Clin Cancer Res 15:6185–6191

    CAS  PubMed  Google Scholar 

  32. Rigi-Ladiz MA, Kordi-Tamandani DM, Torkamanzehi A (2011) Analysis of hypermethylation and expression profiles of APC and ATM genes in patients with oral squamous cell carcinoma. Clin Epigenetics 3:6

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Dong SM, Kim H-S, Rha S-H, Sidransky D (2001) Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 7:1982–1986

    CAS  PubMed  Google Scholar 

  34. Song Y, Zhang C (2009) Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression. Cancer Chemother Pharmacol 63:605–613

    CAS  PubMed  Google Scholar 

  35. Yang HJ, Liu VW, Wang Y, Tsang PC, Ngan HY (2006) Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data. BMC cancer 6:212

    PubMed  PubMed Central  Google Scholar 

  36. Cheung TH, Lo KW, Yim SF, Chan LK, Heung MS, Chan CS, Cheung AY, Chung TK, Wong YF (2004) Epigenetic and genetic alternation of PTEN in cervical neoplasm. GynecolOncol 93:621–627

    CAS  Google Scholar 

  37. Qi Q, Ling Y, Zhu M, Zhou L, Wan M, Bao Y, Liu Y (2014) Promoter region methylation and loss of protein expression of PTEN and significance in cervical cancer. Biomed Rep 2:653–658

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Contreras-Paredes A, De la Cruz-Hernández E, Martínez-Ramírez I, Dueñas-González A, Lizano M (2009) E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway. Virology 383:78–85

    CAS  PubMed  Google Scholar 

  39. Rizvi MM, Alam MS, Ali A, Mehdi SJ, Batra S, Mandal AK (2011) Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population. J Cancer Res Clin Oncol 137:1255–1262

    CAS  PubMed  Google Scholar 

  40. Sova P, Feng Q, Geiss G, Wood T, Strauss R, Rudolf V, Lieber A, Kiviat N (2006) Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis. Cancer Epidemiol Biomarkers Prev 15:114–123

    CAS  PubMed  Google Scholar 

  41. Lin YW, Chung MT, Lai HC, De Yan M, Shih YL, Chang CC, Yu MH (2009) Methylation analysis of SFRP genes family in cervical adenocarcinoma. J Cancer Res ClinOncol 135:1665–1674

    CAS  Google Scholar 

  42. Zhou Z, Wang J, Han X, Zhou J, Linder S (1998) Up-regulation of human secreted frizzled homolog in apoptosis and its down-regulation in breast tumors. Int J Cancer 78:95–99

    CAS  PubMed  Google Scholar 

  43. Wang S, Krinks M, Lin K, Luyten FP, Moos M Jr (1997) Frzb, a secreted protein expressed in the Spemann organizer, binds and inhibits WNT-8. Cell 88:757–766

    CAS  PubMed  Google Scholar 

  44. Ko J, Ryu KS, Lee YH, Na DS, Kim YS, Oh YM, Kim IS, Kim JW (2002) Human secreted frizzled-related protein is down-regulated and induces apoptosis in human cervical cancer. Exp Cell Res 280:280–287

    CAS  PubMed  Google Scholar 

  45. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van Engeland M, Toyota M (2004) Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36:417–422

    CAS  PubMed  Google Scholar 

  46. Lee AY, He B, You L, Dadfarmay S, Xu Z, Mazieres J, Mikami I, McCormick F, Jablons DM (2004) Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Oncogene 23(39):6672–6676

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thanks Parul Ahuja, Geetanjali Singhal, Kiran Malik, Rajbala and all the staff of PGIMS, Rohtak for their assistance during sample collection. We also like to thanks all participants enrolled in the study.

Author information

Authors and Affiliations

Authors

Contributions

Conceived of or designed study: LK; RY and SN. Performed research: LK; SS and CY. Analyzed data: LK and GG. Contributed new methods or models: LKand GG. Wrote the paper: LK; GG and RY.

Corresponding author

Correspondence to Ritu Yadav.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethics approval

Ethical approval for conducting this study was obtained from Maharishi Dayanand University Institutional Human Ethical Committee (IHEC) with Number IHEC/2016/80-13.06.16.

Informed consent

A written informed consent was obtained from all the enrolled cases of cervical cancer.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 17 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kadian, L.K., Yadav, R., Nanda, S. et al. High-risk HPV infection modulates the promoter hypermethylation of APC, SFRP1, and PTEN in cervical cancer patients of North India. Mol Biol Rep 47, 9725–9732 (2020). https://doi.org/10.1007/s11033-020-05960-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-020-05960-z

Keywords

Navigation